These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 18302154)
1. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Langbein S; Frederiks WM; zur Hausen A; Popa J; Lehmann J; Weiss C; Alken P; Coy JF Int J Cancer; 2008 Jun; 122(11):2422-8. PubMed ID: 18302154 [TBL] [Abstract][Full Text] [Related]
2. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Xu X; Zur Hausen A; Coy JF; Löchelt M Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656 [TBL] [Abstract][Full Text] [Related]
3. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715 [TBL] [Abstract][Full Text] [Related]
4. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325 [TBL] [Abstract][Full Text] [Related]
5. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. Lucarelli G; Galleggiante V; Rutigliano M; Sanguedolce F; Cagiano S; Bufo P; Lastilla G; Maiorano E; Ribatti D; Giglio A; Serino G; Vavallo A; Bettocchi C; Selvaggi FP; Battaglia M; Ditonno P Oncotarget; 2015 May; 6(15):13371-86. PubMed ID: 25945836 [TBL] [Abstract][Full Text] [Related]
6. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression. Baptista I; Karakitsou E; Cazier JB; Günther UL; Marin S; Cascante M Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408935 [TBL] [Abstract][Full Text] [Related]
8. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476 [TBL] [Abstract][Full Text] [Related]
9. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells. Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172 [TBL] [Abstract][Full Text] [Related]
10. Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation. Heller S; Maurer GD; Wanka C; Hofmann U; Luger AL; Bruns I; Steinbach JP; Rieger J Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044385 [TBL] [Abstract][Full Text] [Related]
11. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer. Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357 [TBL] [Abstract][Full Text] [Related]
12. TKTL-1 expression in lung cancer. Fritz P; Coy JF; Mürdter TE; Ott G; Alscher MD; Friedel G Pathol Res Pract; 2012 Apr; 208(4):203-9. PubMed ID: 22445516 [TBL] [Abstract][Full Text] [Related]
13. Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver. Frederiks WM; Vizan P; Bosch KS; Vreeling-Sindelárová H; Boren J; Cascante M Int J Exp Pathol; 2008 Aug; 89(4):232-40. PubMed ID: 18422600 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Bentz S; Cee A; Endlicher E; Wojtal KA; Naami A; Pesch T; Lang S; Schubert P; Fried M; Weber A; Coy JF; Goelder S; Knüchel R; Hausmann M; Rogler G Digestion; 2013; 88(3):182-92. PubMed ID: 24193262 [TBL] [Abstract][Full Text] [Related]
15. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Boros LG; Puigjaner J; Cascante M; Lee WN; Brandes JL; Bassilian S; Yusuf FI; Williams RD; Muscarella P; Melvin WS; Schirmer WJ Cancer Res; 1997 Oct; 57(19):4242-8. PubMed ID: 9331084 [TBL] [Abstract][Full Text] [Related]
16. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer. Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961 [TBL] [Abstract][Full Text] [Related]
17. Evidence for transketolase-like TKTL1 flux in CHO cells based on parallel labeling experiments and (13)C-metabolic flux analysis. Ahn WS; Crown SB; Antoniewicz MR Metab Eng; 2016 Sep; 37():72-78. PubMed ID: 27174718 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma. Zhang S; Yue JX; Yang JH; Cai PC; Kong WJ Cancer Biol Ther; 2008 Apr; 7(4):517-22. PubMed ID: 18296915 [TBL] [Abstract][Full Text] [Related]
19. A key role for transketolase-like 1 in tumor metabolic reprogramming. Diaz-Moralli S; Aguilar E; Marin S; Coy JF; Dewerchin M; Antoniewicz MR; Meca-Cortés O; Notebaert L; Ghesquière B; Eelen G; Thomson TM; Carmeliet P; Cascante M Oncotarget; 2016 Aug; 7(32):51875-51897. PubMed ID: 27391434 [TBL] [Abstract][Full Text] [Related]
20. Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy. Zhen X; Zhang M; Hao S; Sun J Biomed Pharmacother; 2024 Jul; 176():116935. PubMed ID: 38876050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]